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Recent studies have demonstrated that bullous pemphigoid 
(BP) antigen. in extracts of cultured human keratinocytes and 
normal human epidermis. is a 230-kD polypeptide. How-
ever. other recent studies have suggested that there is hetero-
geneiry ofBP antigen at the molecular level. To demonstrate 
that this 230-kD polypeptide is the major BP antigen and to 
further characterize it. we tested multiple BP sera by both 
immunoprecipitation of extracts of radiolabeled cultured 
human keratinocytes and immunoblotting of extracts of nor-
mal human epidermis. Thirry-six of37 BP sera immunopre-
cipitated the 230-kD polypeptide. and 11 of 13 BP sera iden-
ti fied the 230-kD polypeptide by immunoblotting. 
Eighry-six disease and normal control sera did not bind the 
230-kD BP antigen. Immunoprecipitation was a more sensi-
tive assay than was immunoblotting to detect the 230-kD 
antigen; BP sera that were weak or negative by immunoblot-
ting were strongly positive by immunoprecipitation. To 
demonstrate that this 230-kD polypeptide shared epitopes. 
Bullous pemphigoid (BP) is an aU[oimmune disease clinically characterized by tense blisters. Blisters de-velop because of cleft formation between epidermis and dermis at the basement membrane zone (DMZ). Patients with BP have antibodies and factors of the 
complement cascade bound to the BMZ of strari6ed squamous 
epichelia. In addition, circulating antibodies chat bind to the DMZ 
of stratified squamous epithelia arc present in most patients [11. The 
binding of dlese antibodies, as determined ultrastructurally, occurs 
within the lamina lucida and also, as has been shown recently, to the 
hemidesmosomes of basal keratinocytes [2-6J. These anti-BMZ 
antibodies from BP patients are probably pathogenic through the 
activation of complement [7]. 
The autoantibodies from BP patients bind [0 an epidermal DMZ 
antigen that is highly preserved in all vertebrates l8]. Therefore, 
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50S: sodium dodecyl sulf.ne 
TDS; 10 mM Tris-HCI. 0.15 M NaCl, pH 7.4 
defined by BP sera. with the epidermal basement membrane 
zone. we showed that BP IgG affiniry purified on this poly-
peptide bound the epidermal basement membrane zone by 
immunofluorescence. To further characterize the BP antigen 
and to compare the antigen synthesized by cultured human 
keratinocytes to the antigen extracted from epidermis. we 
analyzed the 230-kD BP antigen by two-dimensional gel 
electrophoresis. BP antigen immunoprecipitated from cul-
ture extracts or BP antigen identified by immulloblots of 
epidermal extracts was a single spot on [Wo-dimensional gels, 
with a pi of about 8. These data indicate that. although other 
polypeptides are sometimes identified (e.g .• a 166 kD band by 
immunoprecipitation or a 180 kD band on immunoblots). 
the major BP antigen identified in cultured human keratino-
cytes is similar to the antigen found in normal human epi-
dermis and is a basic 230-kD polypeptide. ] Illvest Dermatol 
92:33-38. 1989 
these autoamibodjes define a normal component of the BMZ of 
stratified squamous epithelia (probably a part of the hemidesmo-
some). Recent studies from our laboratory have demonstrated chat 
UP sera from different patients identify a protein of approximately 
230 kO that is synthesized by keratinocytes in culture [9.10] and 
also demonstrable in extracts of normal human epidennis [111. 
Studies in another laboratory have confirmed that a 230-kD DP 
antigen is detected in culture extracts [5J. This protein is distinct 
from other known BMZ molecules. including laminin, which is 
also synthesized by keratinocytes in culture [tOJ. However, some 
studies have suggested that there may ~ heterogeneicy of DP anti-
gen; i.e., sera from different patients bind to different molecules. 
For example, immunofluorescence absorption studies have shown 
that lower molecular weight proteins (20. 9.2, and 18 kD) extracted 
from skin [12] and urine [13] bind BP antibodies. More recent stud-
ies have not detected these low molecular weight polypeptides but 
have still suggested a heterogeneity of the antigen. Immunofluores-
cence studies with different substrates have shown different patterns 
of binding for different BP sera, suggesting heterogeneity of the 
antigen [141. In addition, a recent immunoblotting study found 
that. although the 230-k.0 polypeptide was the polypeptide most 
often recognized by DP sera, less than one-half ofBP sera bound the 
230-kO protein. and some sera bound other polypeptides [15]. 
The purpose of this study was to determine whether rhe 230-kD 
polypeptide is indeed the major DP antigen and to further character-
ize it. Specifically, we wanted to determine 1) what percentage of 
BP sera bind the 230-kD antigen as determined by immunoprecipi-
tation of cultured human keratinocyte extracts compared with im-
munoblotting of epidennal extracts; 2) whether rhe antibodies that 
bind the 230-kO polypeptide also bind the epidermal BMZ; and 3) 
whether the BP antigen extracted from epidermis is similar to that 
synthesized in culture. 
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MATERIALS AND METHODS 
Sera Thirty-seven sera from patients with BP were used to iden-
tify the BP ami gen. Most of these sera were sent to us from othcr 
medical ccntcrs as se ra from patients with "typica)" clinical and/or 
histologic UP. W e srudied only those sera containing antibodies 
that bound to the BMZ of stratified squamous epithelia at a titer of 
equal to or greater than 20, as determined by indirect immunofluo-
rescence with a normal human skin or monkey esophagus substrate. 
If there was any doubt as to the clinical and/or histologic diagnosis, 
we performed indirect immunofluorcscence on a normal human 
skin substrate incubated in 1 M NaCI at 4° for 72 h, as described by 
Gammon cr al r16] . Twelvc of the se ra were thus tested, and all 
showed IgG binding to thc roof of thc split skin, as typical for BP. 
W e did not havc the experience of Gammon etal [171 in which they 
report rhat about 10% of " BP" sera from other medical centers are 
actually epiderrnolysis hullosa acquisita sera. Sera from patients with 
pemphigus or epidermolysis bullosa acquisita and from normal 
humans were used as comrols. 
Extraction of Human Epidermis To identify proteins that spe-
cifically bind BP antibodies on immunoblots, we obtained normal 
human epidermis by incubating dermatomed skin strips in 1 M 
NaCI, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 1 mM 
ethylenediamineretraacetare (EOTA) at 4 ° for 72 h liB] . To extract 
the UP antigen from the separated epidermis, we performed a se-
quential extraction [19]. The epidermis was first extracted with 
10 mM Tris-HcI (PH 7.4) buffer containing 0.5% Nonidet P-40, 
0.1 M dithiothreitol (DTT), 1 mM PMSF, and 2 mM EDTA. The 
pellet, after centrifugation at 100,000 X g for 30 min, was then 
exmceed with extraction buffer (62.5 mM Tris-HCI (pH 6.8) 
buffer containing 2% sodium dodecyl sulfate [SOS], 6 M urea, 
0.1 M DTT, 1 mM PMSF, and 2 mM EDTA). The solubilized 
proteins were heated at 100° for 2 min and then used for the im-
mUl1oblocting and elurion studies discussed below. 
Radiolabeling and Extraction of Cell Cultures T o character-
ize the BP antigen synthesized by human keratinocytes in culture, 
we culrured epidermal cells from human foreskins to near con-
flucncy on 3T3 ce lls with metabolically labeled t"e-amino acids as 
previously reported [20]. Radioactive proteins were extracted with 
0.5% Nonidet P-40 and used for immunoprecipitation [20]. 
Irnmunoprecipitation Immunoprecipitations of radiolabeled 
extracts from cultured human keratinocytes with protein A-bearing 
staphylococci were carried out as previously described 120]. Im-
munoprecipitatcs were eluted ei ther with sample buffer 1 (2% SOS 
in 62.5 111M Tris-H CI, pH 6.8) or sample buffer 2 (9.5 M urea, 2% 
Nonidet P-40, 20 mM DTT in H20) at 100· for 2 min. Eluates of 
immunoprecipitates were analyzed by SOS-polyacrylamide gel 
electrophoresis (PAGE) [20J or by two-dimensional gel electropho-
resis [isoelectric focusing (IEF) followed by SDS-PAGEJ, as de-
scribed below. 
SDS-PAGE and Two-Dimensional Gel Electrophoresis 
Both epidermal extracts and immunoprecipitates were separated by 
two-dimensional gel electrophoresis with I.EF in the horizontal 
direction and SDS-PAGE in the vertical direction, as described by 
O'Farrell 121J. Those immunoprecipitates eluted with sample 
buffer 1 and the epidermal extracts were adjusted to 9.5 M urea, 
then sample dilution buffer [9.5 M urea, 8% Nonidet P-40, 5% 
ampholines (pH 3.5 -9.5; LKB, Gaithersburg, MD), 20 mM DTTJ 
was added in a ratio of2 to I volume of sample according to Ames 
and Nikaido [22}. After cooling to room temperature, ampholines 
(pH 3.5-9.5) were added to those immunoprecipitates eluted with 
sample buffer 2 to a final concentration of2%. The immunoprccipi-
tates and epidermal ext racts thus treated were subjected to IEF in 
rube gels followed by SDS-PAGE [2 1 ,231. After electrophoresis, the 
rad iolabeled immunoprecipitated polypeptides wcre visualized by 
fluorography, whereas ril e nonlabelcd polypeptides extracted from 
epidermis were transferred to nitrocellulose for immunoblotting. 
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Immunoblotting of Extracts of Normal Human Epidermis 
Epidermal extracts subjected to 50S-PAGE or cwo-dimensional gel 
electrophoresis were electrophoretically transferred to nitrocellu-
lose and stained by rhe immunoperoxidase method with DP and 
control sera as previously described [23J. 
Affinity Purification of BP IgG on tbe 230-kD BP Antigen 
To detcrmine whether the SP serum an tibodies that bind the 230-
kD BP antigen also bind the epidermal BMZ, ex tracts of normal 
human epidermis were separated by SOS-PAGE in 16 adjacent lanes 
and then electrophoretically transferred to nitrocellulose paper. 
The maximum amount of extract that did not distort the lane on 
SOS-PAGE was determined, and was subsequently used for these 
experiments. Two vertical strips corresponding to the first and last 
lanes were cut our and stained by the immunopcroxidase method to 
idelltify the BP antigen. These two strips were then used to locate 
the unstained BP antigen in the remaining 14 lanes on the nitrocel-
lulose paper. A t -cm-wide horizontal strip containing the 14 lanes 
of BP anti gen was then cut out. A control strip of cqual width just 
below the area where the BP antigen was located was also cut. Each 
strip was incubated with 2.5 011 DP serum diluted 1: 250 in 0.5% 
Tween 20 in 10 mM Tris-HCI,0. 15 M NaCI (pH 7.4) (TBS) over-
night. After the strips were washed with 0.5% Tween 20/TBS 3 
times and briefly with H20, the antibodies were eluted twice with 
1 M NaCI, 50 mM glycine, pH 2.3, at 37" for 30 min. The eluate 
was collected and immediately neutralized with 500 mM 





















Figure 1. 230-kD .:mtigen immunoprecipitated from extracts of cultured 
human keratinocytes . Fluorography of SDS-PAGE-separated. I"C-:unino 
acid-labeled, immunoprecipitates with DP or normal human sera (C) shows 
a 230-kD polypeptide (tJrrol',y specifically precipitated by UP seu, but not by 
normal human sera. Note that serum UP #238 also precipitates orher, lower 
molecular weight. polypeptides thar are unique for this serum. Migration of 
molecular weighr markers (200. 116 and 97 kD) is shown on the right-hand 
side of the gel. 
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20/TBS, the strips were again incubated with the diluted BP serum, 
and the elution and neutralization were repeated. The eluate from 
four horizo ntal strips was dialyzed against TBS and then concen-
trated on an Amicon PM-10 filter (Amicon Corp., Lexington, MA) 
to about 4 mi. then further concentrated to about 60 JII on a micro-
concentrator Centricon 30 (Amicon Corp.). Thus, the final anti-
body was obtained from two elutions off of each of four strips of 
nitrocellulose, each strip comprising 14 lanes of antigen. The re-
sulting concentrate was used for indirect immunofluorescence ei-
ther undilu ted or at a dilution of 1 : 2. The amount of IgG in the 
final volume was not determined because of its extremely low 
amount, and to preserve antibody. 
Indirect lm.munoHuorescence T he concentrated cluates were 
used to determine if lilC affinity-purified antibody bound the epi-
dermal BMZ in the same way as BP se ra do. Routine immunofluo-
rescence, with pig skin as the substrate and a fluorescein isotit io-
cyanate-conjugated goat anti-human IgG (Tago. Burlingam, C A) 
second antibody, was performed as previously described [24]. 
RESULTS 
A 230-kD Polypeptide Is the Major BP Antigen in Culrured 
Keratinocytes and in N ormal Human Epidermis Immuno-
precipitation of HC-amino acid-labeled proteins ,extracted from 
cultured human keratinocytes demollStrated that se ra from 36 of37 
DP patients precipitated an approximately 230-kD polypeptide 
(Figs t , 2B, 3, and 6). In addition, immunoblotting of extracts of 
normal hUlllan epidermis showed that t t of 13 BP se ra stained a 
230-kD polypeptide band (Figs 2A and 7). Eighty-six disease (pem-
phigus and epidermolysis bullosa acquisita) and normal control se ra 
did not bind this polypeptide in these assays. The speci ficity of the 
reactivity of only BP sera with the 230-kD polypeptide suggests 





















Figure 2. Antibodies in BP senlln #230do no r bind the 230-kD fiP anrigen 
by immunobloning but do immunoprecipit3te the: BP 2ntigen. A : Immuno-
blotofSDS-PAGEof nornul human epidermal extracts shows that DP #56 
st:1ins th e 230-kD BP ant igen (a rrow), but BP #230 does not. A no rmal 
human serum (N HS) was used as control . B: SDS·PAG£ofimmunoprccipi-
lalion of a I'e-Iabeled eXln.el of cu ltured human keratinocytcs shows th:1I 
UP #230 precipitltcs the 230-kD antigen (arrow) to the same ex tent as a 
contro l 13J> (# 446) seru m. Migration of molecular weight sundards are 
show n 0 11 tltt right. 
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Figure 3. BP sera precipitate a minor 166-kD polypeptide (arrowhead) in 
addition to (he major 230-kD polypeptide (arrow) . This 166-kD band is see n 
in v.riabl C' degrees from experiment to ex~riment (C'.g., contrast Fig 1). See 
legend of Fig 1 for details. 
W e found that, in genera l, immunoblotting was not as sensi[ive 
:liS immunoprecipitation in detecting tlte BP antigen. For example. 
one BP se rum (#230) that did not bind the 230-kD polypeptide by 
immunobloning did illllllunoprecipit3te the antigen as well as any 
of the other BP sera (Fig 2, also see Fig 2 of Ref 25). In addition, 
several se ra that weakly stained the 230-kD band by immunoblot-
-- -
Figure -4. Immunoperoxicbse staining of nitrocd lulose strips u~d to affin-
ity purify SP IgG on the 230-kD poly~ptide band. The vertical strips are 
routine immunoblots of epidermal extracts and wC're u~d to locate multiple 
bands o f unstained UP aflrigC'n on the upper horizontal strip. This ho rizontal 
strip (and a ho rizontal strip below it . u~d as control) were incubated with BP 
serum and washed. and then till: BP IgG was dutC'd. The incubarion and 
d ution were repeated: then. after the second dution, the ho rizontal strips 
were stained with peroxidase conjugated goat :lIlti-humanlgG. The staining 
of the IlP antigC'o after elution was noticeably weaker than in the vertical 
l1neluted sidC' strips. 
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Figure S. Indirf'cr immunofluorf'scence demonstrates that BP antibodies 
affinity punfied by the 230~kD BP antigen bind the epidermal BMZ (A) . BP 
serum affinity purified by the same method. but not on the 230-kD polypep-
tide. do not staIn the epiderma1 BMZ (B). (X2S0). 
ting precipitated the 230-kD polypeptide as strongly as any of the 
other BP sera. 
As reported by others [15], we somerimes did find that some BP 
sera precipitated or stained polypeptides other than the 230-kD BP 
antigen (e.g., BP #238, Fig I). Usually, as is the case of BP #238, 
this reactivity was unique to one particular serum. However, by 
immunoprecipitation (but nor by immunoblorting), we did find 
that most BP sera sometimes precipitated, in addition to [he 230-kD 
band, a 166-kD band of variable intensity depending on the particu-
lar immunoprecipitation (Fig 3). Because of the variability in the 
precipitation of this 166-kD band, we suspect that it may represent 
breakdown of the 230-kD polypeptide. On the other hand, the 
unique bands that were precipitated Or stained by individual se ra 
may represent separate antibody systems in these sera either to anti-
gens unrelated to BP antigen or to heterogeneous BP antigens. 
BP IgG Affinity Purified on the Z30-kD Polypeptide Binds 
tbe Epidermal BMZ To demonstrate that the antibodies that 
bind the 230-kD polypeptide are actually those that bind the epi-
dermal BMZ, we affinity purified BP antibodies on the 230-kD 
polypeptide. as described in the M~II,oJs, and then used these anti-
bodies for immunofluorescence. Figure 4 shows the immunoperox-
idase staining of one set of nitrocellulose strips used in this affinity 
purific2tion. BP IgG was eluted from the 14 lanes shown in the 
upper horizontal strip. The weaker staining of the DP antigen with 
peroxidase conjugated goat antihuman IgG after elution of the BP 
IgG is consistent with the observation that BP IgG was, in fact, 
eluted from the 230-kD band. As a control, a horizontal strip just 
below the BP antigen band was cut out, incubated with BP serum, 
and eluted in the same way. The antibodies affinity purified on the 
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230-kD polypeptide bound the epidermal BMZ, as determined by 
immunofluorescence, w hereas antibodies eluted from the control 
strip did not (Fig 5). These results indicate that the 230-kO poly-
peptide contains antigenic sites found in the epidermal BMZ. 
BP Antigen from Cultured Cells Is Similar to BP Antigen 
from Normal Human Epidermis To furthet characterize the 
230-kD BP antigen and to further compare the antigen synthesized 
by cultured keratinocytes to the antIgen exrracted from human epi-
dermis, we analyzed the BP antigen by rwo~dimensional gel elec~ 
trophoresis. Immunoprecipitates of radio labeled extracts of cul-
tured keratinocytes were eluted with either 9.5 M urea (sample 
buffer 2) at 100 0 or 2% SDS (sample buffer 1) at 1000 • Two-dimen-
sional gel electrophoresis of these el uates demonstrated that both 
elution methods gave similar results; namely, that all fiP sera tested 
precipitate a 230-kD polypeptide with pi approxim:ncly 8, which 
appears as a single spot (Fig 6) . Immunoblots with BP sera of human 
epidermal extracts separated by two-dimensional gel electrophore-
sis also demonstrated a single spot of molecular weigh t approxi-
mately 230,000 and pI approximately 8 (Fig 7). The pI of the 
lEF 
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Figure 6. Two-dimension .. 1 gel electrophoresis of the BP antige n immu-
noprecipitated by vuious BP sera from extracts of cultured hum .. n keratino-
cytes.lmmunoprecipitates were eluted with sample buffer I (rightcolumtl) or 
sample blJffer 2 (lift colurntl). After electrophoretic separation :md f1uorogra-
phy, BP antigen is seen as a single spot with a moleclJl.u weight of 230.000 
and an isoelectric point of B. Migration of molecular weight marke" is 
shown on the right-frond lid~ of upper gels. and the pH gr:adient is shown 
across the top. 



















Figure 7. BP antigen detected by two-dimensional gel e1ecrrophoresis fol-
lowed by immunoblotting of normal human epidermal extracts. BP sera 
identify a single spot of molecular weight 230,000 and pI approximately 8 
(arrow). A normal human serum was used as a control. 
230-kD BP antigen extracted from epidermis appeared to be 
slightly more acidic than that of the antigen from culture, but this 
may represent experimental variability in measuring pI in different 
experiments. 
These results confirm the specificity of BP sera for one m~jor 
230-kD polypeptide and demonstrate that it is similar whether ex-
tracted from cell culture or epidermis. 
DISCUSSION 
In this study we have demonstrated that a 230-kD basic protein is 
the major BP antigen. By immunoprecipitation of extracts of cul-
cured kerarinocy[es, > 95% of BP sera bound [he 230-kD polypep-
tide. Two-dimensional gel electrophoresis of this precipitated poly-
peptide indicated a single spot with pI approximately 8. By 
immunoblotting of extracts of normal epidermis. > 80% of sera 
bound [he 230-kD polypeptide. Immunoblo" with BP sera of epi-
dermal extracts separated by two-dimensional gel electrophoresis 
also indicated a single spot of pI approximately 8. The above results 
define BP antigen, as have all previous studies, on the specificity of 
BP serum binding co the antigen. They do not directly demonstrate 
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that the antibodies that bind the putative BP antigen are actually 
[hose [hac bind [he epidermal BMZ. We. therefore, funher proved 
that this 230-kD polypeptide is BP antigen by demonstrating that 
BP IgG eluted from rhis 230-kD polypeptide bound the epidermal 
BMZ by indirect immunofluorescence. 
Other studies suggest that BP antigen may be heterogeneous 
[14,15]' Immunoblot studies with multiple BP sera have shown 
that, although the 230-kD band represents the polypeptide most 
often recognized by BP sera, < 50% of BP sera recognize it [15]. 
Although we found that a higher percentage of BP sera react with 
the 230-kD molecule by immunoblotting, we did find that immu-
noblotting is less sensitive than immunoprecipitation. Our results 
suggest that, once denatured for SDS-PAGE and subsequent im-
munoblotting, the 230-kD BP antigen loses or decreases its im-
munoreactivity with some sera. On the other hand, the antigen-an-
tibody reaction in immunoprecipitation takes place before the harsh 
denaturation of SDS-PAGE, and therefore, immunoprecipitation 
may be more sensitive. 
As reponed by ocher "udies [! 5J, we did find, by both immuno-
precipitation and immunoblorting. that some BP sera bound poly-
peptides other than the 230-kD antigen. For some sera, the bands 
identi.fi.ed were unique for each particular serum. This type of reac-
tivity may represent either another BP antigen or an antigen unre-
lated to the epidermal DMZ. We also noted that many BP sera, in 
addition to immunoprecipitating the 230-kD polypeptide, precipi-
tated a 166-kD polypeptide. This polypeptide was present in vary-
ing degrees in different experiments, suggesting that it may repre-
sent a degradation product (perhaps a specific metabolic product) of 
the 230-kD polypeptide. This 166-kD polypep[ide might also be 
[he same as the 180-kD band [hac Labib e[ al [15J reported was 
stained by several BP sera on inununoblots. However, on our im-
munoblots we did not detcct cither a 166- or 180-kD band. The 
reason for this discrepancy remains elusive. but may be related to the 
protease inhibitors used in the epidermal extraction procedure. We 
used only PMSF and EDT A; however. Labib e[ al [! 5] used, in 
addition, pepstatin, antipain, leupeptin, and cymostatin. Perhaps 
these additional protease inhibitors prevented degradation of the 
IBO-kD band. Whatever the explanation for why different minor 
antigens are dctected with BP sera, it remains to be determined how, 
and even if, these other antigens arc related to the major 230-kD BP 
antigen. 
The distinctive two-dimensional gel electrophoresis pattern of 
BP antigen as a single spot should be helpful in finding abnormali-
tics in this antigen in hereditary diseases that might affect the 
antigen, such as junctional epidermolysis bullosa in which there 
is usually a defect in hemidesmosomes [26]. Finally, the immuno-
reactivity with this 230-kD antigen should be useful to diagnose 
cases of BP with unusual clinical features or to determine if these 
cases represent autoimmune diseases with autoantibodies directed 
against a different component of the BMZ. 
We (hallie Drs. W. Ray Gammon, Mitla Yaar, Walter uller. Erns( Beumer. 
Thomas Ray, E. Abel,j. D. Fit/e. a"d Russell Hal/for provjdit'g BP major this 
$wdy. 
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2ND MEETING OF THE PANAMERICAN SOCIETY 
FOR PIGMENT CELL RESEARCH 
The Second Meeting of rhe PanAmcrican Society for Pigment Cell Research will be held 
from Apri l 23-26, t 989. at the Hyatt Regency in Bethesda, Maryland. This date was chosen 
to coincide with the TriSocicries Dermatology Meeting. which is being held in Washington, 
D.C., bter chat same week. It is our hope that this schedule will allow a maxi mum number of 
scientists to attend who are interested in all aspects of normal and transformed pigment cells. 
Spring ill our narion's capicol is a lovely season. In addition to the excellen t meeti ng facility 
available at the H yatt Regency, our scienti fi c program will be supplemented by social events 
including a conference dinner and entertainment at the Kennedy Center for the Performing 
Arts. For further information COlUact VincemJ. Hearing, Ph.D., Laboracory of Cell Biology, 
Building 37, Room Ill22, National lnsticutes of Health, Bethesda, MD 20892 USA. 
